Author:
Romero Otero J.,Justo Quintas J.,García Rojo E.,Sopeña Sutil R.,Peña Vallejo E.,Lista Mateos F.,Bozzini G.,Saenz Calzada D.,Rodríguez Antolín A.,García Gómez B.
Reference21 articles.
1. The development of human benign prostatic hyperplasia with age;Berry;J Urol.,1984
2. The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: A systematic analysis for the Global Burden of Disease Study 2019;Lancet Healthy Longev.,2022
3. European Association of Urology [Internet]. Management of non-neurogenic male LUTS. Disease management. Arnhem: EAU; 2022 [consultado 27 Nov 2022]. Disponible en: https://uroweb.org/guidelines/management-of-non-neurogenic-male-luts/chapter/disease-management
4. Long-term results of open transvesical prostatectomy from a contemporary series of patients;Varkarakis;Urology.,2004
5. HoLEP: The new gold standard for surgical treatment of benign prostatic hyperplasia;Shvero;Can J Urol.,2021